Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Marvin Frank who wrote (1618)	9/15/1998 10:13:00 PM
From: WILLIAM BLACK	Read Replies (1) \| Respond to of 4140

Marvin: I talked to Susan at Sunrise yesterday. She indicated that all the patients in the Phase 111 have been treated and they are waiting for followup on the procedure. This could take some time to complete. They are working on the PMA which should be submitted to FDA this fall with expected final approval late 1999. She said everything is going fine and no problems as far as she has heard. I think the previous post concerns the trial using the procedure to correct the errors using the LASIK for nearsightedness. This is another procedure for which Sunrise is seeking FDA approval. Bill Black